Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Terbiface plus NF Cream:
Terbiface plus NF Cream is a combination of two medications designed to effectively treat contagious skin diseases. It targets and eliminates the parasites responsible for the infection while alleviating inflammation symptoms such as redness, swelling, and itching.
Terbiface plus NF Cream should be used regularly to derive the maximum benefit. Excessive usage is not recommended as it won't expedite the clearance of your condition and may only exacerbate the outcomes. Skin infections typically improve within 2 to 6 weeks. Do not continue using the medication for longer than advised by your physician, and consult them if your condition does not improve after the recommended treatment duration. Maintaining cleanliness and dryness in the affected area and washing hands while treating the infection can enhance the medication's effectiveness.
Uses of Terbiface plus NF Cream:
Treatment of Fungal skin diseases
Benefits of Terbiface plus NF Cream:
In Treatment of Fungal skin diseases:
Terbiface plus NF Cream is utilized to manage and control fungal infections such as athlete's foot (infection between toes), jock itch (infection of the groin area), ringworm, and other fungal skin infections (candidiasis). It also provides relief from pain, redness, itching, burning sensation, and accelerates the healing process. Improvement in skin condition may be observed within 4-5 days. Continue using Terbiface plus NF Cream for the prescribed duration.
Mechanism of action of Terbiface plus NF Cream:
Terbiface plus NF Cream is a combination of two medications: Mometasone and Terbinafine, which treat skin infections. Mometasone, a steroid medication, inhibits the production of certain chemical messengers (prostaglandins) responsible for skin redness, swelling, and itching. Terbinafine, an antifungal agent, halts the growth of fungi by preventing them from forming their protective covering.